Ruffer LLP Makes New $17.62 Million Investment in The Cooper Companies, Inc. $COO

Key Points

• Ruffer LLP has made a new investment of $17.62 million in The Cooper Companies, acquiring 247,662 shares of $COO, which now represents 0.8% of its investment portfolio.
• The Cooper Companies' CEO, Albert G. White III, and COO, Daniel G. Mcbride, both made insider purchases of the company's stock, indicating confidence in its value.
• The company has initiated a $2.00 billion buyback program, allowing for the reacquisition of up to 15.4% of its stock, often interpreted as a sign that the stock is undervalued.

Ruffer LLP acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 247,662 shares of the medical device company's stock, valued at approximately $17,624,000. Cooper Companies comprises 0.8% of Ruffer LLP's investment portfolio, making the stock its 29th biggest holding. Ruffer LLP owned about 0.12% of Cooper Companies as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. Public Employees Retirement System of Ohio grew its position in shares of Cooper Companies by 2.9% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,843 shares of the medical device company's stock worth $4,401,000 after buying an additional 1,741 shares during the period. Covea Finance grew its position in shares of Cooper Companies by 41.3% during the 2nd quarter. Covea Finance now owns 65,000 shares of the medical device company's stock worth $4,625,000 after buying an additional 19,000 shares during the period. Mitchell & Pahl Private Wealth LLC grew its position in shares of Cooper Companies by 12.0% during the 2nd quarter. Mitchell & Pahl Private Wealth LLC now owns 9,716 shares of the medical device company's stock worth $691,000 after buying an additional 1,041 shares during the period. Diversified Trust Co grew its position in shares of Cooper Companies by 20.8% during the 2nd quarter. Diversified Trust Co now owns 12,360 shares of the medical device company's stock worth $880,000 after buying an additional 2,131 shares during the period. Finally, Assenagon Asset Management S.A. grew its position in shares of Cooper Companies by 19.0% during the 2nd quarter. Assenagon Asset Management S.A. now owns 240,446 shares of the medical device company's stock worth $17,110,000 after buying an additional 38,457 shares during the period. 24.39% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Albert G. White III acquired 10,000 shares of the company's stock in a transaction dated Friday, September 5th. The shares were bought at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the purchase, the chief executive officer directly owned 226,151 shares in the company, valued at approximately $15,466,466.89. This trade represents a 4.63% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Daniel G. Mcbride acquired 3,000 shares of the company's stock in a transaction dated Tuesday, September 2nd. The shares were bought at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the purchase, the chief operating officer owned 63,120 shares in the company, valued at approximately $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 15,975 shares of company stock worth $1,079,566. 1.98% of the stock is currently owned by company insiders.

Cooper Companies Trading Up 1.3%

NASDAQ:COO opened at $68.35 on Thursday. The Cooper Companies, Inc. has a twelve month low of $61.78 and a twelve month high of $111.44. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The business has a 50 day moving average price of $70.36 and a two-hundred day moving average price of $74.71. The company has a market cap of $13.59 billion, a P/E ratio of 33.67, a price-to-earnings-growth ratio of 1.77 and a beta of 0.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the prior year, the firm posted $0.96 EPS. The business's revenue was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a share repurchase program on Wednesday, September 17th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock buyback programs are often an indication that the company's leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on COO. Morgan Stanley set a $76.00 target price on Cooper Companies and gave the stock an "equal weight" rating in a research report on Thursday, August 28th. Robert W. Baird decreased their price objective on Cooper Companies from $97.00 to $85.00 and set an "outperform" rating for the company in a research report on Thursday, August 28th. Loop Capital set a $100.00 price objective on Cooper Companies in a research report on Tuesday, June 17th. UBS Group upgraded Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Finally, JPMorgan Chase & Co. decreased their price objective on Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Cooper Companies presently has a consensus rating of "Moderate Buy" and an average target price of $86.64.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.